Cholesterol drug setback casts doubt over multibillion-dollar race
· cnbc.com
Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.
In this article NVS
IONS
AMGN Follow your favorite stocks CREATE FREE ACCOUNT
Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images ...